Wall Street brokerages expect Ceridian HCM Holding Inc (NYSE:CDAY) to post earnings of $0.08 per share for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have made estimates for Ceridian HCM’s earnings, with the lowest EPS estimate coming in at $0.05 and the highest estimate coming in at $0.12. The firm is scheduled to report its next earnings results on Monday, February 4th.
According to Zacks, analysts expect that Ceridian HCM will report full year earnings of ($0.09) per share for the current year, with EPS estimates ranging from ($0.14) to ($0.01). For the next financial year, analysts anticipate that the business will report earnings of $0.46 per share, with EPS estimates ranging from $0.43 to $0.49. Zacks’ earnings per share calculations are an average based on a survey of analysts that cover Ceridian HCM.
Ceridian HCM (NYSE:CDAY) last issued its quarterly earnings data on Monday, October 29th. The company reported $0.05 earnings per share for the quarter, beating analysts’ consensus estimates of $0.02 by $0.03. Ceridian HCM had a negative net margin of 2.25% and a positive return on equity of 2.64%. The business had revenue of $179.60 million for the quarter, compared to analysts’ expectations of $176.29 million. The firm’s quarterly revenue was up 9.8% on a year-over-year basis.
Shares of NYSE CDAY traded up $0.70 during midday trading on Friday, reaching $37.04. 790,134 shares of the company traded hands, compared to its average volume of 662,256. Ceridian HCM has a 52 week low of $28.65 and a 52 week high of $44.98. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.03 and a current ratio of 1.03.
In related news, CFO Arthur Gitajn sold 135,755 shares of Ceridian HCM stock in a transaction dated Tuesday, October 23rd. The stock was sold at an average price of $36.18, for a total value of $4,911,615.90. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Cannae Holdings, Inc. sold 4,396,694 shares of Ceridian HCM stock in a transaction dated Friday, November 16th. The stock was sold at an average price of $34.70, for a total value of $152,565,281.80. The disclosure for this sale can be found here.
Institutional investors and hedge funds have recently modified their holdings of the stock. JS Capital Management LLC purchased a new position in Ceridian HCM in the 2nd quarter worth about $6,638,000. BlackRock Inc. purchased a new position in Ceridian HCM in the 2nd quarter worth about $28,814,000. Waddell & Reed Financial Inc. purchased a new position in Ceridian HCM in the 2nd quarter worth about $20,880,000. Mackay Shields LLC purchased a new position in Ceridian HCM in the 2nd quarter worth about $1,286,000. Finally, K2 Principal Fund L.P. purchased a new position in Ceridian HCM in the 2nd quarter worth about $2,906,000. 70.02% of the stock is currently owned by hedge funds and other institutional investors.
About Ceridian HCM
Ceridian HCM Holding, Inc engages in the provision of human capital management services. It operates through Human Capital Management (HCM), and LifeWorks segments. The Human Capital Management segment includes cloud solutions, dayforce and powerplay, as well as bureau HCM solutions. The LifeWorks segment reflects the results of LifeWorks joint venture.
Recommended Story: How To Calculate Debt-to-Equity Ratio
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.